Safety and Effectiveness of First-line Endovascular Management of Low-Grade Brain Arteriovenous Malformations : Single Center Experience in 145 Patients.
Embolization
Intracranial arteriovenous malformations
Pressure cooker technique
Surgery
Journal
Clinical neuroradiology
ISSN: 1869-1447
Titre abrégé: Clin Neuroradiol
Pays: Germany
ID NLM: 101526693
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
received:
26
11
2021
accepted:
15
04
2022
pubmed:
14
5
2022
medline:
15
12
2022
entrez:
13
5
2022
Statut:
ppublish
Résumé
Spetzler-Martin grade (SMG) I-II (low-grade) brain arteriovenous malformations (BAVMs) are often considered safe for microsurgical resection; however, the role of endovascular treatment (EVT) remains to be clarified in this indication, especially for unruptured BAVMs. The purpose of our study was to assess the safety and effectiveness of endovascular treatment as the first-line treatment for low-grade BAVMs. From our local database, we retrospectively retrieved patients with low-grade BAVMs, either ruptured or unruptured, treated by embolization as first-line treatment in our department between January 2005 and January 2020. The primary endpoint was the total obliteration rate of BAVMs, and secondary endpoints were hemorrhagic complications and final clinical outcome, assessed through shift of the modified Rankin scale, and mortality rate secondary to BAVM embolization. A total of 145 patients meeting inclusion criteria and treated by EVT as first-line therapy were included in the study (82 ruptured and 63 unruptured BAVMs). Overall, complete exclusion of BAVMs was achieved in 110 patients (75.9%); 58 patients (70.7%) with ruptured and 52 (82.5%) unruptured BAVMs, including 37.9% BAVMs excluded by EVT alone (35.5% among ruptured and 44.4% among unruptured BAVMs) and 38% by combined treatment (EVT and surgery or EVT and SRS). There was no BAVM volume cut-off predictive for total obliteration by embolization alone. Early minor hemorrhagic complications were reported in 14 patients (9.6%) and early major hemorrhagic complications were reported in 5 patients (3.4%). No late hemorrhagic complications (0%) occurred; mortality rate was 0.7% (1/145 patients). Improved/unchanged mRS was reported in 137 patients (94.5%). Endovascular treatment alone or associated with others exclusion techniques, might be safe and effective for complete exclusion of low-grade brain arteriovenous malformations regardless of the volume.
Identifiants
pubmed: 35551419
doi: 10.1007/s00062-022-01176-9
pii: 10.1007/s00062-022-01176-9
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1019-1029Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.
Références
Al-Shahi R, Bhattacharya JJ, Currie DG, Papanastassiou V, Ritchie V, Roberts RC, Sellar RJ, Warlow CP, Scottish Intracranial Vascular Malformation Study Collaborators. Prospective, population-based detection of intracranial vascular malformations in adults: the Scottish Intracranial Vascular Malformation Study (SIVMS). Stroke. 2003;34:1163–9.
doi: 10.1161/01.STR.0000069018.90456.C9
Hamilton MG, Spetzler RF. The prospective application of a grading system for arteriovenous malformations. Neurosurgery. 1994;34:2–6. discussion 6–7.
Mohr JP, Parides MK, Stapf C, Moquete E, Moy CS, Overbey JR, Al-Shahi Salman R, Vicaut E, Young WL, Houdart E, Cordonnier C, Stefani MA, Hartmann A, von Kummer R, Biondi A, Berkefeld J, Klijn CJ, Harkness K, Libman R, Barreau X, Moskowitz AJ, international ARUBA investigators. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet. 2014;383:614–21.
doi: 10.1016/S0140-6736(13)62302-8
van Beijnum J, van der Worp HB, Buis DR, Al-Shahi Salman R, Kappelle LJ, Rinkel GJ, van der Sprenkel JW, Vandertop WP, Algra A, Klijn CJ. Treatment of brain arteriovenous malformations: a systematic review and meta-analysis. JAMA. 2011;306:2011–9.
doi: 10.1001/jama.2011.1632
Morgan MK, Rochford AM, Tsahtsarlis A, Little N, Faulder KC. Surgical risks associated with the management of Grade I and II brain arteriovenous malformations. Neurosurgery. 2004;54:832–7; discussion 837–9.
doi: 10.1227/01.NEU.0000114264.78966.BE
Potts MB, Lau D, Abla AA, Kim H, Young WL, Lawton MT, UCSF Brain AVM Study Project. Current surgical results with low-grade brain arteriovenous malformations. J Neurosurg. 2015;122:912-20.
doi: 10.3171/2014.12.JNS14938
Baharvahdat H, Blanc R, Fahed R, Smajda S, Ciccio G, Desilles JP, Redjem H, Escalard S, Mazighi M, Chauvet D, Robert T, Sasannejad P, Piotin M. Endovascular treatment for low-grade (Spetzler-Martin I-II) brain arteriovenous malformations. AJNR Am J Neuroradiol. 2019;40:668–72.
Iosif C, de Lucena AF, Abreu-Mattos LG, Ala VHE, El-Ghanam A, Saleme S, Caire F, Mounayer C. Curative endovascular treatment for low-grade Spetzler-Martin brain arteriovenous malformations: a single-center prospective study. J Neurointerv Surg. 2019;11:699–705.
doi: 10.1136/neurintsurg-2018-014390
Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M; STROBE Initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology. 2007;18:805–35.
doi: 10.1097/EDE.0b013e3181577511
van Rooij WJ, Jacobs S, Sluzewski M, van der Pol B, Beute GN, Sprengers ME. Curative embolization of brain arteriovenous malformations with onyx: patient selection, embolization technique, and results. AJNR Am J Neuroradiol. 2012;33:1299–304.
doi: 10.3174/ajnr.A2947
Al-Shahi Salman R, White PM, Counsell CE, du Plessis J, van Beijnum J, Josephson CB, Wilkinson T, Wedderburn CJ, Chandy Z, St George EJ, Sellar RJ, Warlow CP, Scottish Audit of Intracranial Vascular Malformations Collaborators. Outcome after conservative management or intervention for unruptured brain arteriovenous malformations. JAMA. 2014;311:1661–9.
doi: 10.1001/jama.2014.3200
Derdeyn CP, Zipfel GJ, Albuquerque FC, Cooke DL, Feldmann E, Sheehan JP, Torner JC, American Heart Association Stroke Council. Management of brain arteriovenous malformations: a scientific statement healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2017;48:e200–24.
doi: 10.1161/STR.0000000000000134
Sussman ES, Iyer AK, Teo M, Pendharkar AV, Ho AL, Steinberg GK. Interventional therapy for brain arteriovenous malformations before and after ARUBA. J Clin Neurosci. 2017;37:54–6.
doi: 10.1016/j.jocn.2016.10.036
Wong J, Slomovic A, Ibrahim G, Radovanovic I, Tymianski M. Microsurgery for ARUBA Trial (A Randomized Trial of Unruptured Brain Arteriovenous Malformation)-Eligible unruptured brain arteriovenous malformations. Stroke. 2017;48:136–44.
doi: 10.1161/STROKEAHA.116.014660
Javadpour M, Al-Mahfoudh R, Mitchell PS, Kirollos R. Outcome of microsurgical excision of unruptured brain arteriovenous malformations in ARUBA-eligible patients. Br J Neurosurg. 2016;30:619–22.
doi: 10.1080/02688697.2016.1181153
Magro E, Gentric JC, Batista AL, Kotowski M, Chaalala C, Roberge D, Weill A, Stapf C, Roy D, Bojanowski MW, Darsaut TE, Klink R, Raymond J. The Treatment of Brain AVMs Study (TOBAS): an all-inclusive framework to integrate clinical care and research. J Neurosurg. 2018;128:1823–9.
doi: 10.3171/2017.2.JNS162751
Herial NA, Khan AA, Sherr GT, Qureshi MH, Suri MF, Qureshi AI. Detachable-tip microcatheters for liquid embolization of brain arteriovenous malformations and fistulas: a United States single-center experience. Neurosurgery. 2015;11 Suppl 3:404–11; discussion 411.
Maimon S, Strauss I, Frolov V, Margalit N, Ram Z. Brain arteriovenous malformation treatment using a combination of Onyx and a new detachable tip microcatheter, SONIC: short-term results. AJNR Am J Neuroradiol. 2010;31:947–54.
doi: 10.3174/ajnr.A1959
Herial NA, Khan AA, Suri MF, Sherr GT, Qureshi AI. Liquid embolization of brain arteriovenous malformation using novel detachable tip micro catheter: a technical report. J Vasc Interv Neurol. 2014;7:64–8.
Chapot R, Stracke P, Velasco A, Nordmeyer H, Heddier M, Stauder M, Schooss P, Mosimann PJ. The pressure cooker technique for the treatment of brain AVMs. J Neuroradiol. 2014;41:87–91.
doi: 10.1016/j.neurad.2013.10.001
Spetzler RF, Martin NA. A proposed grading system for arteriovenous malformations. J Neurosurg. 1986;65:476–83.
doi: 10.3171/jns.1986.65.4.0476
Sundt TM Jr, Piepgras DG, Stevens LN. Surgery for supratentorial arteriovenous malformations. Clin Neurosurg. 1991;37:49–115.
Aboukaïs R, Quidet M, Baroncini M, Bourgeois P, Leclerc X, Vinchon M, Lejeune JP. Grade 1 Spetzler and Martin cerebral ruptured arteriovenous malformations treated by microsurgery: poor functional outcome is related to injury from haemorrhage. Neurochirurgie. 2017;63:69–73.
doi: 10.1016/j.neuchi.2016.10.010
Moon K, Levitt MR, Almefty RO, Nakaji P, Albuquerque FC, Zabramski JM, Wanebo JE, McDougall CG, Spetzler RF. Safety and efficacy of surgical resection of unruptured low-grade arteriovenous malformations from the modern decade. Neurosurgery. 2015;77:948–52; discussion 952–3.
doi: 10.1227/NEU.0000000000000968
Wang A, Mandigo GK, Feldstein NA, Sisti MB, Connolly ES, Solomon RA, Lavine SD, Meyers PM. Curative treatment for low-grade arteriovenous malformations. J Neurointerv Surg. 2020;12:48–54.
doi: 10.1136/neurintsurg-2019-015115
Hung AL, Yang W, Westbroek EM, Garzon-Muvdi T, Caplan JM, Braileanu M, Wang JY, Colby GP, Coon AL, Tamargo RJ, Huang J. Differences in functional outcome across subtypes with Spetzler-Martin Grade II arteriovenous malformations. Neurosurgery. 2017;81:441–9. Erratum in: Neurosurgery. 2017;80:991.
doi: 10.1093/neuros/nyw140
Davidson AS, Morgan MK. How safe is arteriovenous malformation surgery? A prospective, observational study of surgery as first-line treatment for brain arteriovenous malformations. Neurosurgery. 2010;66:498–504; discussion 504–5.
doi: 10.1227/01.NEU.0000365518.47684.98
Gross BA, Duckworth EA, Getch CC, Bendok BR, Batjer HH. Challenging traditional beliefs: microsurgery for arteriovenous malformations of the basal ganglia and thalamus. Neurosurgery. 2008;63:393–410; discussion 410–1.
doi: 10.1227/01.NEU.0000316424.47673.03
Liu KD, Lee LS. Microsurgical treatment of deep arteriovenous malformations--basal ganglia and thalamus. Zhonghua Yi Xue Za Zhi (Taipei). 2001;64:23–30.
Lawton MT, Hamilton MG, Spetzler RF. Multimodality treatment of deep arteriovenous malformations: thalamus, basal ganglia, and brain stem. Neurosurgery. 1995;37:29–35; discussion 35–6.
doi: 10.1227/00006123-199507000-00004
Graffeo CS, Sahgal A, De Salles A, Fariselli L, Levivier M, Ma L, Paddick I, Regis JM, Sheehan J, Suh J, Yomo S, Pollock BE. Stereotactic radiosurgery for Spetzler-Martin Grade I and II arteriovenous malformations: International Society of Stereotactic Radiosurgery (ISRS) Practice Guideline. Neurosurgery. 2020;87:442–52.
doi: 10.1093/neuros/nyaa004
Kano H, Lunsford LD, Flickinger JC, Yang HC, Flannery TJ, Awan NR, Niranjan A, Novotny J Jr, Kondziolka D. Stereotactic radiosurgery for arteriovenous malformations, Part 1: management of Spetzler-Martin Grade I and II arteriovenous malformations. J Neurosurg. 2012;116:11–20.
doi: 10.3171/2011.9.JNS101740
Ding D, Starke RM, Kano H, Mathieu D, Huang PP, Kondziolka D, Feliciano C, Rodriguez-Mercado R, Almodovar L, Grills IS, Silva D, Abbassy M, Missios S, Barnett GH, Lunsford LD, Sheehan JP. Stereotactic radiosurgery for ARUBA (A Randomized Trial of Unruptured Brain Arteriovenous Malformations)-eligible Spetzler-Martin Grade I and II arteriovenous malformations: a multicenter study. World Neurosurg. 2017;102:507–17.
doi: 10.1016/j.wneu.2017.03.061